Bombardier Statement Regarding Alstom Request for Arbitration

Written by Customer Service on April 25, 2022. Posted in Public Companies.

MONTRÉAL, April 25, 2022 (GLOBE NEWSWIRE) — Bombardier (TSX: BBD.B) today announced that it has received a notice from Alstom S.A. requesting arbitration before the International Chamber of Commerce pursuant to the agreement relating to the sale by Bombardier of its Transportation business (Transportation) on January 29, 2021 (the Transaction). In its request for arbitration, Alstom is alleging that Bombardier is in breach of certain contractual provisions. Bombardier has good grounds to defend itself against Alstom’s claim and intends to do so vigorously. As noted in its press release dated January 29, 2021, Bombardier also intends to challenge certain purchase price adjustments which resulted in proceeds from the Transaction being lower than initially estimated. Arbitration proceedings could last several years. Given that Bombardier...

Advanced Emissions Solutions to Host First Quarter 2022 Conference Call on May 10th

Written by Customer Service on April 25, 2022. Posted in Public Companies.

GREENWOOD VILLAGE, Colo., April 25, 2022 (GLOBE NEWSWIRE) — Advanced Emissions Solutions, Inc. (NASDAQ: ADES) (the “Company” or “ADES”) today announced the Company expects to release its first quarter 2022 financial results and file its Quarterly Report on Form 10-Q for the period ended March 31, 2022 after market close on Monday, May 9, 2022. A conference call to discuss the Company’s financial performance is scheduled to begin at 9:00 a.m. Eastern Time on Tuesday, May 10, 2022. The conference call webcast information will be available via the Investor Resources section of ADES’s website at www.advancedemissionssolutions.com. Interested parties may also participate in the call by registering at https://events.q4inc.com/attendee/666425897. A supplemental investor presentation will be available...

SOUTHERN MISSOURI BANCORP REPORTS PRELIMINARY RESULTS FOR THIRD QUARTER OF FISCAL 2022; DECLARES QUARTERLY DIVIDEND OF $0.20 PER COMMON SHARE; CONFERENCE CALL SCHEDULED FOR TUESDAY, APRIL 26, AT 9:30AM CENTRAL TIME

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

Poplar Bluff, Missouri, April 25, 2022 (GLOBE NEWSWIRE) — Southern Missouri Bancorp, Inc. (“Company”) (NASDAQ: SMBC), the parent corporation of Southern Bank (“Bank”), today announced preliminary net income for the third quarter of fiscal 2022 of $9.4 million, a decrease of $2.1 million, or 18.4%, as compared to the same period of the prior fiscal year. The decrease was attributable to an increase in noninterest expense and provision for credit losses, partially offset by increases in net interest income and noninterest income, and by a decrease in provision for income taxes. Preliminary net income was $1.03 per fully diluted common share for the third quarter of fiscal 2022, a decrease of $.24 as compared to the $1.27 per fully diluted common share reported for the same period of the prior fiscal year. Provision for credit losses...

<div>Brown & Brown, Inc. announces quarterly revenues of $904.7 million, an increase of 11.0%, diluted net income per share of $0.77, Diluted Net Income Per Share - Adjusted of $0.78 and a quarterly dividend of $0.1025 per share</div>

Brown & Brown, Inc. announces quarterly revenues of $904.7 million, an increase of 11.0%, diluted net income per share of $0.77, Diluted Net Income Per Share – Adjusted of $0.78 and a quarterly dividend of $0.1025 per share

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

DAYTONA BEACH, Fla., April 25, 2022 (GLOBE NEWSWIRE) — Brown & Brown, Inc. (NYSE:BRO) (the “Company”) today announced its unaudited financial results for the first quarter of 2022. Revenues for the first quarter of 2022 under U.S. generally accepted accounting principles (“GAAP”) were $904.7 million, increasing $89.4 million, or 11.0%, compared to the first quarter of the prior year, with commissions and fees increasing by 11.1% and Organic Revenue increasing by 7.8%. Income before income taxes was $265.0 million, increasing 10.8% from the prior year with Income Before Income Taxes Margin remaining consistent with the prior year at 29.3%. EBITDAC – Adjusted was $323.3 million, increasing 11.1% from the prior year with EBITDAC Margin – Adjusted remaining consistent with the prior year at...

Grupo Aeroportuario del Pacifico Announces Results for the First Quarter of 2022

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

GUADALAJARA, Mexico, April 25, 2022 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V. (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) reported its consolidated results for the first quarter ended March 31, 2022 (1Q22) (tables are presented at the end of this report comparing passenger traffic and consolidated results for 2022 and 2019, in order to illustrate the recovery of these metrics and their trend). Figures are unaudited and have been prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). COVID-19 Impact During the first quarter ended March 31, 2022, passenger traffic increased 69.9% as compared to the same period of 2021 and increased 5.8% as compared to 2019, demonstrating a positive trend. This increase, which...

German American Bancorp, Inc. (GABC) Reports First Quarter 2022 Earnings

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

JASPER, Ind., April 25, 2022 (GLOBE NEWSWIRE) — German American Bancorp, Inc. (Nasdaq: GABC) reported first quarter earnings of $9.1 million, or $0.31 per share. The current quarterly earnings include the results of Citizens Union Bancorp of Shelbyville, Inc. (“CUB”), which, as previously reported, was acquired by German American on January 1, 2022. The first quarter of 2022 included one-time merger and acquisition costs of approximately $11.7 million and “Day 1” provision under the current expected credit loss (“CECL”) model for CUB of $6.3 million (total impact of $13.6 million, or $0.46 per share, on an after-tax basis). As a result, quarterly earnings declined by approximately $10.5 million, or 58% on a per share basis, from 2021 first quarter earnings of $19.6 million, or $0.74 per share. Total...

SmartFinancial Announces Results for the First Quarter 2022

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

Highlights for the First Quarter of 2022 Operating earnings1 of $8.6 million, or $0.51 per diluted common share, for the first quarter of 2022 Net organic loan and lease growth of over $136.9 million – 21% annualized quarter-over-quarter increase Non-time deposit growth of over $195.0 million – 23% annualized quarter-over-quarter increase Credit quality remains solid with nonperforming assets to total assets of 0.11% KNOXVILLE, Tenn., April 25, 2022 (GLOBE NEWSWIRE) — SmartFinancial, Inc. (“SmartFinancial” or the “Company”; NASDAQ: SMBK), today announced net income of $8.3 million, or $0.49 per diluted common share, for the first quarter of 2022, compared to net income of $9.8 million, or $0.65 per diluted common share, for the first quarter of 2021, and compared to prior quarter net income of $6.7...

Monroe Capital Corporation Schedules First Quarter 2022 Earnings Release and Conference Call

Written by Customer Service on April 25, 2022. Posted in Public Companies.

CHICAGO, April 25, 2022 (GLOBE NEWSWIRE) — Monroe Capital Corporation (the “Company”) (NASDAQ: MRCC) announced today that it will report its first quarter 2022 financial results on Tuesday, May 3, 2022, after the close of the financial markets. The Company will host a webcast and conference call to discuss these operating and financial results on Wednesday, May 4, 2022 at 11:00 am ET. The webcast will be hosted on a webcast link located in the Investor Relations section of our website at http://ir.monroebdc.com/events.cfm. To participate in the conference call, please dial (877) 312-8807 approximately 10 minutes prior to the call. Please reference conference ID # 9371837. For those unable to listen to the live broadcast, the webcast will be available for replay on the Company’s website approximately two hours after the event. ABOUT...

Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases

Written by Customer Service on April 25, 2022. Posted in Public Companies.

DUBLIN, Ireland and CHICAGO, April 25, 2022 (GLOBE NEWSWIRE) — Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced two poster presentations at the 32nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) being held April 23-26, 2022 in Lisbon, Portugal. The poster presentations at ECCMID were as follows: Title: In Vitro Activity of Sulopenem and Comparator Agents Against Anaerobic Clinical Isolates from the SENTRY Surveillance Program 2018-2020Presenting Author: Steven AroninPoster Session: 5a. Mechanisms of action, new compounds, preclinical data & pharmacology of antibacterial agents Title:...

PharmaTher Reports Financial Results for the Third Quarter of Fiscal 2022 and Provides Recent Business Highlights and Update

Written by Customer Service on April 25, 2022. Posted in Earnings Releases And Operating Results.

Nearly $12 million in cash and investment Fully funded for the Company’s development programs, including ketamine injection and infusion product, ketamine microneedle patch and ketamine wearable pump device for mental health, neurological, and pain disorders Seeking FDA approval for KETARX™ (ketamine injection and infusion product) for anesthesia and procedural sedation TORONTO, April 25, 2022 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today reported financial results for its third quarter ended February 28, 2022, and provided recent business highlights and update. All amounts are stated in Canadian dollars unless otherwise indicated. “We have made great progress with our product and clinical development programs for ketamine...

Day: April 25, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice